Martin Price

Views & Analysis

The world of life sciences is changing rapidly, and the traditional ways of assessing drugs may no longer be fit for purpose.

News

Armed with new phase 3 data, Bayer is preparing to file a PET imaging agent that could accelerate the diagnosis of cardiac amyloidosis.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.